BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16166288)

  • 21. [The reproduction in France of Rosen's protocol for osteosarcomas].
    Brunat-Mentigny M; Demaille MC; Quitana E; Olive D; Bachelot C; Boitetot A; Gentet JC; Noir P; Roche H; Thyss JP
    Bull Cancer; 1988; 75(2):201-6. PubMed ID: 2451955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
    Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
    J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
    Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M
    Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.
    Souhami RL; Craft AW; Van der Eijken JW; Nooij M; Spooner D; Bramwell VH; Wierzbicki R; Malcolm AJ; Kirkpatrick A; Uscinska BM; Van Glabbeke M; Machin D
    Lancet; 1997 Sep; 350(9082):911-7. PubMed ID: 9314869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.
    Wunder JS; Bull SB; Aneliunas V; Lee PD; Davis AM; Beauchamp CP; Conrad EU; Grimer RJ; Healey JH; Rock MJ; Bell RS; Andrulis IL
    J Clin Oncol; 2000 Jul; 18(14):2685-94. PubMed ID: 10894867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
    Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
    J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
    Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
    Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
    [No Abstract]   [Full Text] [Related]  

  • 30. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
    Kalifa C; Mlika N; Dubousset J; Contesso G; Vanel D; Lumbroso J
    Bull Cancer; 1988; 75(2):207-11. PubMed ID: 2451956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
    Wei L; Song XR; Wang XW; Li M; Z uo WS
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
    Chuman H; Fukuma H; Beppu Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
    Uchida A; Myoui A; Araki N; Yoshikawa H; Shinto Y; Ueda T
    Cancer; 1997 Jan; 79(2):411-5. PubMed ID: 9010116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
    Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
    Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Developments in the treatment of osteosarcoma since 1979. Report of the statistics at the Centre Léon-Bérard].
    Brunat-Mentigny M; Biron P; Kohler R; Blondet R; Bérard J; Chauvot P; Bouffet E; Carret JP; Jonas P; Patricot LM
    Bull Cancer; 1990; 77(9):933-40. PubMed ID: 2224166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
    Winkler K; Bieling P; Bielack S; Delling G; Dose C; Jürgens H; Kotz R; Ritter J; Salzer-Kuntschik M
    Clin Orthop Relat Res; 1991 Sep; (270):79-86. PubMed ID: 1715820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.